From NFL Dreams to Life’s Greatest Battle: The Rob Long Story
David Fajgenbaum shared on X:
“Imagine you’re getting ready to be drafted into the NFL, when all of a sudden you get diagnosed with a rare form of brain cancer.
Even worse, there are no approved treatments in the 5 year survival rate is under 15%. Your only hope is that your doctor can find a treatment approved for another condition to save your life.
This is Rob Long’s story. Click the link to watch the full documentary!”
Source: David Fajgenbaum/X
David C. Fajgenbaum is the co-founder and President of the Castleman Disease Collaborative Network (CDCN), the Founding Director of the Center for Cytokine Storm Treatment and Laboratory (CSTL), Associate Director of Patient Impact for the Penn Orphan Disease Center, and an Associate Professor of Medicine in Translational Medicine and Human Genetics at the University of Pennsylvania.
Dr. Fajgenbaum is also the national bestselling author of “Chasing My Cure: A Doctor’s Race to Turn Hope Into Action” and a patient battling idiopathic multicentric Castleman disease (iMCD).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023